Bibliography
- Sidhu SS. Engineering M13 for phage display. Biomol Eng 2001;18:57-63
- Barbas FC, Burton DR, Scott JK, Silverman DJ. Phage Display, A Laboratory Manual. NY: Cold Spring Harbor Laboratory Press; 2001
- Smith GP. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 1985;228:1315-7
- Benhar I. Biotechnological applications of phage and cell display. Biotechnol Adv 2001;19:1-33
- Jespers LS, Roberts A, Mahler SM, et al. Guiding the selection of human antibodies from phage display repertoires to a single epitope of an antigen. Biotechnology 1994;12:899-903
- Hoogenboom HR, de Bruine AP, Hufton SE, et al. Antibody phage display technology and its applications. Immunotechnology 1998;4:1-20
- O'Connell D, Becerril B, Roy-Burman A, et al. Phage versus phagemid libraries for generation of human monoclonal antibodies. J Mol Biol 2002;321:49-56
- Becerril B, Poul MA, Marks JD. Toward selection of internalizing antibodies from phage libraries. Biochem Biophys Res Commun 1999;255:386-93
- Petrenko VA, Sorokulova IB. Detection of biological threats. A challenge for directed molecular evolution. J Microbiol Methods 2004;58:147-68
- Chen L, Zurita AJ, Ardelt PU, et al. Design and validation of a bifunctional ligand display system for receptor targeting. Chem Biol 2004;11:1081-91
- Arap W, Pasqualini R, Ruoslahti E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science 1998;279:377-80
- Trepel M, Arap W, Pasqualini R. In vivo phage display and vascular heterogeneity: implications for targeted medicine. Curr Opin Chem Biol 2002;6:399-404
- Webster R. Filamentous phage biology. In: Phage Display: A Laboratory Manual. Barbas FC, editor. NY: Cold Spring Harbor Laboratory Press; 2001. p. 1-37
- Giordano RJ, Cardo-Vila M, Lahdenranta J, et al. Biopanning and rapid analysis of selective interactive ligands. Nat Med 2001;7:1249-53
- Hajitou A, Baramova EN, Bajou K, et al. FGF-3 and FGF-4 elicit distinct oncogenic properties in mouse mammary myoepithelial cells. Oncogene 1998;17:2059-71
- Kelly KA, Waterman P, Weissleder R. In vivo imaging of molecularly targeted phage. Neoplasia 2006;8:1011-8
- Brown EB, Campbell RB, Tsuzuki Y, et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy. Nat Med 2001;7:864-8
- Massoud TF, Gambhir SS. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003;17:545-80
- De S, Chen J, Narizhneva NV, et al. Molecular pathway for cancer metastasis to bone. J Biol Chem 2003;278:39044-50
- Koukourakis MI, Giatromanolaki A, Brekken RA, et al. Enhanced expression of SPARC/osteonectin in the tumor-associated stroma of non-small cell lung cancer is correlated with markers of hypoxia/acidity and with poor prognosis of patients. Cancer Res 2003;63:5376-80
- Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-91
- Rusckowski M, Gupta S, Liu G, et al. Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agent. J Nucl Med 2004;45:1201-8
- Rubin RH, Young LS, Hansen WP, et al. Specific and nonspecific imaging of localized Fisher immunotype 1 Pseudomonas aeruginosa infection with radiolabeled monoclonal antibody. J Nucl Med 1988;29:651-6
- Segers J, Laumonier C, Burtea C, et al. From phage display to magnetophage, a new tool for magnetic resonance molecular imaging. Bioconjug Chem 2007;18:1251-8
- Laumonier C, Segers J, Laurent S, et al. A new peptidic vector for molecular imaging of apoptosis, identified by phage display technology. J Biomol Screen 2006;11:537-45
- Merril CR, Biswas B, Carlton R, et al. Long-circulating bacteriophage as antibacterial agents. Proc Natl Acad Sci USA 1996;93:3188-92
- Zou J, Dickerson MT, Owen NK, et al. Biodistribution of filamentous phage peptide libraries in mice. Mol Biol Rep 2004;31:121-9
- Molenaar TJ, Michon I, de Haas SA, et al. Uptake and processing of modified bacteriophage M13 in mice: implications for phage display. Virology 2002;293:182-91
- Poul MA, Becerril B, Nielsen UB, et al. Selection of tumor-specific internalizing human antibodies from phage libraries. J Mol Biol 2000;301:1149-61
- Kassner PD, Burg MA, Baird A, Larocca D. Genetic selection of phage engineered for receptor-mediated gene transfer to mammalian cells. Biochem Biophys Res Commun 1999;264:921-8
- Poul MA, Marks JD. Targeted gene delivery to mammalian cells by filamentous bacteriophage. J Mol Biol 1999;288:203-11
- Larocca D, Baird A. Receptor-mediated gene transfer by phage-display vectors: applications in functional genomics and gene therapy. Drug Disc Today 2001;6:793-801
- Larocca D, Jensen-Pergakes K, Burg MA, Baird A. Receptor-Targeted gene delivery using multivalent phagemid particles. Mol Therap 2001;3:476-84
- Mount JD, Samoylova TI, Morrison NE, et al. Cell targeted phagemid rescued by preselected landscape phage. Gene 2004;341:59-65
- Urbanelli L, Ronchini C, Fontana L, et al. Targeted gene transduction of mammalian cells expressing the her2/neu receptor by filamentous phage. J Mol Biol 2001;313:965-76
- Uppala A, Koivunen E. Targeting of phage display vectors to mammalian cells. Comb Chem High Throughput Screen 2000;3:373-92
- Galanis A, Vile R, Russell SJ. Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Crit Rev Oncol Hematol 2001;38:177-92
- Hajitou A, Trepel M, Lilley CE, et al. A hybrid vector for ligand-directed tumor targeting and molecular imaging. Cell 2006;21(125):385-98
- Pasqualini R, Koivunen E, Ruoslahti E. Alpha v. integrins as receptors for tumor targeting by circulating ligands. Nat Biotechnol 1997;15:542-6
- Ellerby HM, Arap W, Ellerby LM, et al. Anti-cancer activity of targeted pro-apoptotic peptides. Nat Med 1999;5:1032-8
- Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature. Science 2002;296:2404-7
- Turton JA, Andrews CM, Havard AC, Williams TC. Studies on the haemotoxicity of chloramphenicol succinate in the Dunkin Hartley guinea pig. Int J Exp Pathol 2002;83:225-38
- Yacoby I, Shamis M, Bar H, et al. Targeting antibacterial agents by using drug-carrying filamentous bacteriophages. Antimicrob Agents Chemother 2006;50:2087-97
- Yacoby I, Bar H, Benhar I. Targeted drug-carrying bacteriophages as anti-bacterial nanomedicines. Antimicrob Agents Chemother 2007;51:2156-63
- Kovacs EW, Hooker JM, Romanini DW, et al. Dual-surface-modified bacteriophage MS2 as an ideal scaffold for a viral capsid-based drug delivery system. Bioconjug Chem 2007;18:1140-7
- Summers WC. Bacteriophage therapy. Ann Rev Microbiol 2001;55:437-51
- Carlton RM. Phage therapy: past history and future prospects. Arch Immunol Ther Exp (Warsz) 1999;47:267-74
- Hooker JM, Datta A, Botta M, et al. Magnetic resonance contrast agents from viral capsid shells: a comparison of exterior and interior cargo strategies. Nano Lett 2007;7:2207-10
- Emerich DF. Nanomedicine: prospective therapeutic and diagnostic applications. Expert Opin Biol Ther 2005;5:1-5